Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 11Not yet recruiting 2Active not recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Motor Activity 3Breast Neoplasms 3Neoplasms 2Triple Negative Breast Neoplasms 1Sarcopenia 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Obesity 1Neoplasm Metastasis 1Hematopoietic and Lymphatic System Neoplasm 1Fatigue 1Cholangiocarcinoma 1

Interventions

pembrolizumab 25Cyclophosphamide 20Nivolumab 13Doxorubicin 13Carboplatin 10Surveys and Questionnaires 9Paclitaxel 9Exercise 9atezolizumab 8Vincristine 8Rituximab 8Radiotherapy 8Prednisone 8Dexamethasone 8Bevacizumab 8venetoclax 7fludarabine 7Pemetrexed 7Fluorouracil 7Docetaxel 7Blood Specimen Collection 7lenvatinib 6dostarlimab 6cemiplimab 6budigalimab 6Oxaliplatin 6Cisplatin 6durvalumab 5Leucovorin 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasms × Resistance Training × Clear all
NCT07159815 2026-06-01

REACT

Inland Norway University of Applied Sciences

Phase NA Active not recruiting
160 enrolled
Tumor-Agnostic

Neoplasms

NCT05650827 2025-05-14

Feasibility and Effect of Resistance Training and Protein Supplementation in Patients With Advanced Gastroesophageal Cancer

Rigshospitalet, Denmark

Phase NA Active not recruiting
54 enrolled

Neoplasms, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡